Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This is a new interview. Post Tox PR.
Thank you for taking the time to document and post your observations.
Now there's a question sure to elicit an entertaining exchange. Like a trailer to a good comedy. Step right up all, enjoy the show!
Welcome to the board. I look forward to your contributions.
The updated site rolled out about noon PT yesterday.
Website redesign.
Nanoviricides.com
Echo that. Thanks BK. You are a good teacher. Your students are lucky.
My mistake.
Research continues on HIVCide. A recently as September a press release regarding improved effectiveness conducted at Souther Research Institute. While not a top priority, and hopefully not a resource drain, efforts on other pipelines continue.
http://www.marketwatch.com/story/nanoviricides-reports-it-has-successfully-improved-hivcide-drug-candidate-in-cell-culture-studies-2013-09-16
Let's be honest. You're not looking for a price of $3.00 before Tox results you are hoping to that price. You are not an investor in NNVC, you hold a grudge against Dr. S and you use this board as your soap box. Your predictions are empty and I might add boring. You offer nothing of value to this board. Do your haunting somewhere else.
Not "everyone". Your posts are very good. You are not alone or exceptional in your understanding and appreciation of Nanoviricides. There are many who have contributed to the board, for many years. Thank you for continuing the tradition and for providing good feedback. And thank you to the many others.
I'm pleased that the non-GLP Tox testing has begun. The departure from plan, Kard versus Basi for step 1, is a bone sure to be chewed by the board.
"Here boy, here you go. That's a good fella. Chew on it, satisfy that need to fight."
Too true. Still the insightful solutions proffered make the detour down pundit lane worth the departure from NNVC speculation and banter. If only congress would read this board. The analysis; innovative, insightful, reflective (acoustically), surely could solve all of America's financial troubles. Now I know where America's brilliant Economists have been hiding.
Please, stop posting here, America needs your service.
Not mad. Not worth it. Just correcting misinformation.
I've been to Nanoviricides' offices, yes office space above a "warehouse". The office is modest. No shareholder dollars wasted on amenities. I've also toured the Shelton Plant, in progress, and I was extremely pleased with the layout and construction progress.
No fraud. No duplicity. Just dedicated visionaries hard at work.
Fraud? Look no further then sokinlavv.
Thank you. Well said. Educational.
...and that's another thing. Many here are hoping to get to an island! Aloha NYSE-MKT.
It is exactly the exchange many here expected. Today's PR is the culmination of a well executed business plan. Indicators have been provided throughout. Start with BK's post, follow with a review of NanoViricides' new releases and presentations.
Congratulations Dr. S. Dr. D and all shareholders.
And if you want to extend the potential even further...Viricides are host independent. How many times have you heard Dr Seymour make that statement? Well, there's opportunity in livestock-pharm to be explored.
Pigs get the flu. Livestock of all kinds suffer viral illnesses. After we've run the table on Flu, Dengue, HIV/Aides, Herpes, MERS..... how about a division of NanoViricides to protect livestock from epidemic? How much do you imagine Smithfield would be willing to spend to save its 5 billion dollar business?
Fun.
If you don't agree with the wisdom and strategy sell. Institutional investors will scoop up your shares. Long and strong.
The troika has reassembled. The bile will increase exponentially while they are in attendance. GLTA through the dog days of summer. I'm stepping out to get some fresh air. I can't abide the insults and unsubstantiated accusations that have been and will continue to be posted by the trio of dogs. There are more civil sources of information.
Long on NNVC. Confident in the science and Management. Assured by my own eyes and ears that progress is being made and funds are being spent prudently and wisely.
Thanks to those who have posted informative and insightful words.
An excellent post. Thank you.
I'm sure you can work this out.
My answer was too glib. I do apologize. FluCide will cure within 24 hours. No need for a combined treatment. No need for Tamiflu.
FluCide would cure you. Tamiflu would do little or nothing and make money. Next time just take FluCide and stop needlessly lining Roche's pockets.
You've earned the right to crow. Congratulations.
Pace yourselves.
There is a ways to go and deals, though they may come, should be delayed until Phase I/II are well in hand if not complete.
NanoViricides has cash on hand. As PPS increases additional funds and favorable terms can be secured.
NanoViricides can afford to shoulder the burden of risk for a time. Today they are marketing promise wrapped in risk. There is value to promise.
In 12 to 18 months NanoViricides will be in a position to shop proven, independently validated, anti-viral cures. Be patient. Give Management time and they will have product. Product wrapped in certainty. There is value in proven product...monumental value.
Pace yourselves.
It is typical to distribute information to press in advance of public release, under embargo, with a explicit date/time of release. Cox violated the embargo. (Fact, not a judgement, indictment or accusation of wrong doing.)
The SEC 8-k acknowledges the event formally as is required by regulation.
As I recall you have accused both Drs.. Diwan and Seymour of running a "lifestyle" scam. Your point of view is tainted and far too bias to be taken seriously. You have disqualified yourself as a legitimate commentator on this board.
I consider the PHE agreement to be a statement of good faith by the premier voice of disease control and public health care in the UK. This is an endorsement of value to the market.
Happy Independence Day to all.
I do agree that there is a disconnect between Cox reference to a PHE agreement and the link to the EMA Letter of Intent.
A cliff hanger as he exits AF? He has always demonstrated a dramatic flare.
Odd? I do mark the milestone's significance. I believe that application for Orphan Designation from the EMA is a terrific move. But why cite the EMA application as the biggest event in six years mere weeks after application for FDA Orphan Designation?
One could combine the two events and cite pursuit of Orphan Designation as hugely significant but singling our the EMA application is puzzling. Is there a critical difference between the EMA and FDA designation?
Am I misinterpreting your post or did Gabor's opinion lose something in translation?
Alternatively NanoViricides could go through a process of applying for Orphan Status, Drug Certification, Patent protection country by country through the maze of arcane rules and guidelines in most cases intended to protect local business and squeeze pay offs at every turn. Please consider the alternative.
No problem. Good to have contribution to the board from the horse's mouth.
(Even if today's answer was buy the bull.)
Dr. Diwan at OneMedPlace 6/27/13
http://www.ustream.tv/new/search?q=Nanoviricides
I have traditionally averaged down when I believed in a technology despite market set backs to the company. In this case I lack confidence that my existing investment will see profit. The R/S played out about as poorly as one might imagine. I'm afraid averaging down will turn out to be throwing good money after bad. My personal stratagem, not one I promote for others but the path I'll follow in this case, hold and hope for certification. If certification is achieved there may be a chance to profit in time. GLTA longs.
You are not alone.
Grant money is also a real possibility. I don't disagree. I can imagine grants submitted by Eva Harris getting a boost if the Orphan Drug application is well received. Dr. Harris' lab tests using, systematically refined, DengueCide is an effort worth allocating some resources to. In a feedback informed "tuning"process 50% survival could be elevated to 90% or better. Pretty impressive results against an illness with no existing cure.
That said;
I hope FluCide remains NanoViricides' highest priority.